Sofosbuvir/Velpatasvir/Voxilaprevir Effective As Rescue Treatment In Patients With Chronic HCV Who Do Not Achieve Sustained Virologic Response With Direct-Acting Antiviral Agents, Study Finds
December 06, 2022
Healio (12/5, Altersitz) reports sofosbuvir/velpatasvir/voxilaprevir (Vosevi), “a triple-combination therapy for chronic hepatitis C virus infection, was effective when used as a rescue treatment in patients who did not achieve sustained virologic respons...